DURECT Corporation (DRRX) Announces First Quarter 2013 Financial Results and Update of Programs
5/3/2013 7:19:23 AM
More...
|
DURECT Corporation (DRRX) Invites You to Join Its First Quarter 2013 Earnings Conference Call
4/24/2013 10:18:41 AM
More...
|
DURECT Corporation (DRRX) Announces Submission of New Drug Application for POSIDUR™ (SABER®-Bupivacaine)
4/16/2013 9:49:48 AM
More...
|
DURECT Corporation (DRRX) Announces Fourth Quarter 2012 Financial Results and Update of Programs
3/1/2013 7:36:33 AM
More...
|
DURECT Corporation (DRRX) Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
2/22/2013 7:29:16 AM
More...
|
DURECT Corporation (DRRX) to Participate in Upcoming Healthcare Conferences
2/5/2013 7:10:36 AM
More...
|
DURECT Corporation (DRRX) Announces Positive Results From Relday5 Phase 1 Clinical Trial
1/3/2013 9:04:00 AM
More...
|
DURECT Corporation (DRRX) Announces Pricing of Public Offering of Common Stock
12/6/2012 9:31:38 AM
More...
|
DURECT Corporation (DRRX) to Participate in Upcoming Healthcare Conferences
11/13/2012 9:52:19 AM
More...
|
DURECT Corporation (DRRX) Announces Third Quarter 2012 Financial Results and Update of Programs
11/6/2012 9:57:53 AM
More...
|
|